Global Enzyme-Linked Immunosorbent Assay (ELISA) Market to witness growth during the forecast period 2019-2026 owing to the increasing incidence of chronic diseases such as infectious diseases, vector-borne diseases, and cancer

Hyderabad, April 25, 2019 -- The "Enzyme-Linked Immunosorbent Assay Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.
Enzyme-Linked Immunosorbent Assay Market Dynamics
Drivers
⦁Global Enzyme-Linked Immunosorbent Assay (ELISA) market is primarily driven by the increasing incidence of chronic diseases such as infectious diseases, vector-borne diseases, and cancer.
⦁Moreover, laboratory automation for ELISA assay and the emergence of cost-effective technologies are other factors aiding the growth of ELISA market. For instance, the National Cancer Institute (NCI), in 2016 reported approximately 1.7 million new cases of cancer were diagnosed in the U.S. alone.
⦁The increasing R&D on biomarkers and monoclonal antibodies coupled with the continued growth of drug discovery market owing to the demand for accurate and early diagnosis of disease along with the rising geriatric population are some more major driving factors for the ELISA market.
Restraints
⦁However, the threat of substitution due to the availability of other immunoassays and new technologies such as the multiplex proteomic array platform can hinder or may limit the growth of the market.
Enzyme-Linked Immunosorbent Assay Market Segmentation
⦁By test type, the global enzyme-linked immunosorbent assay (ELISA) market is segmented into sandwich ELISA, multiple and portable ELISA, indirect ELISA, and competitive ELISA. Indirect ELISA segment of the market is projected to the fastest growing share.
⦁This testing method is mainly used for measuring antibodies in almost all human infections. Therefore with the high prevalence of infectious disease and vector-borne diseases such as dengue, yellow fever, and malaria drive this market share.
⦁For instance, the World Health Organization (WHO) stated that more than 2.5 billion people of the world’s population are now at risk of dengue and estimates there may be more than 100 million dengue infections worldwide every year.
⦁By the application, the ELISA market is segmented into immunology, inflammation, infectious diseases, cancer, protein quantification, and others. The immunology market share dominates this market segment regarding revenue owing it to the high sensitivity and specificity of the ELISA test and its ability to do a large number of tests simultaneously.
Enzyme-Linked Immunosorbent Assay Market Geographical Share
⦁Regarding region, North America dominates the global Enzyme-Linked Immunosorbent Assay (ELISA), Market. It can be attributed to the development of innovative products by manufacturers in the region.
⦁Moreover, the commercializing of various private and public sectors research inventions and collaborating with existing market players to carrying out the development in Immunoassay-based clinical diagnostics are expanding the region’s share in the ELISA market.
⦁For instance, in March 2018, BARD1 Life Sciences, a U.S-based Company, is expected to commercialize its BARD1-Ovarian blood-based ELISA test which is used to identify ovarian cancer in early stages.
⦁The company entered into an assay development agreement with Thermo Fisher Scientific for custom research assay development of a multiplex autoantibody test system. It includes the transfer of the current BARD1 assay design to Thermo Fisher for optimization using Thermo Fisher’a ProcartaPlex Technology for BARD1’s research use.
⦁Furthermore, Asia Pacific is projected to be the fastest growing region in ELISA market, owing to the geographical expansion of regional and international players along with introduction enzyme-based test kits at affordable prices.
⦁For instance, in January 2019, AroCell AB announced that a distribution agreement had been signed with the Beijing based company Gongyingshi for the promotion and distribution of the AroCell TK 210 ELISA in China.
Key Points covered in the report
⦁Enzyme-Linked Immunosorbent Assay Market – Methodology and Scope
⦁Enzyme-Linked Immunosorbent Assay Market - Trends
⦁Enzyme-Linked Immunosorbent Assay Market – Industry Analysis
⦁Geographical Analysis
⦁Competitive Landscape
⦁Company Profiles

For more information about this report and to request for a free sample, visit https://www.datamintelligence.com/research-report/enzyme-linked-immunosorbent-assay-market
DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research.

DataM Intelligence 4Market Research is a market intelligence platform which gives access to syndicated, customised reports to its clients at one place. As a firm with rich experience in research and consulting across multiple domains we are one stop solution that will cater to the needs of clients in key business areas.

1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

This release was published on openPR.